Pain points: Unsolved recruitment and trial design issues in pain clinical trials
Although pain affects millions of people worldwide, the industry is still struggling in the ongoing search for safe and effective medication.
Features
Will there ever be a cure for Alzheimer’s disease?
Pipeline Moves: Advancement prospects plunge for Parkinson’s drug after trial termination
Bucking the trend: How the UK can replicate the Greater Manchester model
‘UK commercial clinical trials will double and double again’ – Lord James O’Shaughnessy
Hope for the UK clinical trial landscape but it requires a lot of work
Pipeline Moves: Advancement prospects plunge for Bristol-Myers’ oncology drug after trial termination
Alzheimer’s Disease: Some trials to watch over the next year
